Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zu-Yao Yang

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|October 18, 2024
Definitions of chronic disease need to be more patient centredZu-Yao Yang, Jin-Ling Tang
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 23, 2010
[Application of 'stepped-wedge design' methodology in randomized controlled trials]Zu-yao Yang, Si-yan Zhan
European Heart Journal|January 26, 2021
β-Blocker and survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular diseaseHui Tang, Zu-Yao Yang, Jin-Ling Tang
JAMA|December 22, 2011
Depression and risk of strokeZu-Yao Yang, Chen Mao, Jin-Ling Tang
JAMA Internal Medicine|December 6, 2017
Considerations Concerning Disease RedefinitionZu-Yao Yang, Hong Fan, Jin-Ling Tang
JAMA|June 7, 2011
Bevacizumab and cancer treatment-related mortalityZu-Yao Yang, Chen Mao, Jin-Ling Tang
European Urology|June 5, 2012
Re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2012;61:994-1003Jin-Qiu Yuan, Zu-Yao Yang, Chen Mao
The New England Journal of Medicine|February 24, 2012
Apixaban versus enoxaparin in medically ill patientsZu-Yao Yang, Chen Mao, Tang Jin-Ling Jin-Ling
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 18, 2010
[Detection rate on un-repaired cleft lip/palate patients in Gansu province in 2008]Zheng Shu, Zu-yao Yang, Ruo-gu Meng, et al.
Oncotarget|September 24, 2017
Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysisQi Feng, Zu-Yao Yang, Jia-Tong Zhang, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|October 18, 2024
Definitions of chronic disease need to be more patient centredZu-Yao Yang, Jin-Ling Tang
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 23, 2010
[Application of 'stepped-wedge design' methodology in randomized controlled trials]Zu-yao Yang, Si-yan Zhan
European Heart Journal|January 26, 2021
β-Blocker and survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular diseaseHui Tang, Zu-Yao Yang, Jin-Ling Tang
JAMA|December 22, 2011
Depression and risk of strokeZu-Yao Yang, Chen Mao, Jin-Ling Tang
JAMA Internal Medicine|December 6, 2017
Considerations Concerning Disease RedefinitionZu-Yao Yang, Hong Fan, Jin-Ling Tang
JAMA|June 7, 2011
Bevacizumab and cancer treatment-related mortalityZu-Yao Yang, Chen Mao, Jin-Ling Tang
European Urology|June 5, 2012
Re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2012;61:994-1003Jin-Qiu Yuan, Zu-Yao Yang, Chen Mao
The New England Journal of Medicine|February 24, 2012
Apixaban versus enoxaparin in medically ill patientsZu-Yao Yang, Chen Mao, Tang Jin-Ling Jin-Ling
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 18, 2010
[Detection rate on un-repaired cleft lip/palate patients in Gansu province in 2008]Zheng Shu, Zu-yao Yang, Ruo-gu Meng, et al.
Oncotarget|September 24, 2017
Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysisQi Feng, Zu-Yao Yang, Jia-Tong Zhang, et al.
Pageof 4